Manufacturer Torrent Pharmaceuticals Limited is recalling 36 additional lots of the blood pressure drug losartan potassium and 68 additional lots of losartan-hydrochlorothiazide combination tablets due to detection of trace amounts of the carcinogen N-Methylnitrosobutyric acid (NMBA) above acceptable daily levels set by the U.S. Food and Drug Administration (FDA).
Information about the nationwide recall, including details on products and lots, is available on the FDA website.
To date, there have not been reports of adverse events related to this recall. To learn more about the recall, contact Torrent Pharmaceuticals at (800) 912-9561 or [email protected].
